HOME >> BIOLOGY >> NEWS
Moderate alcohol consumption increases plasma levels of a protective hormone

  • Moderate alcohol consumption is believed to have protective cardiovascular health benefits, possibly through its effects on hormones.
  • Researchers examine alcohol's effect on three hormones: dehydroepiandrosterone sulfate (DHEAS), testosterone and estradiol.
  • Moderate alcohol consumption appears to increase plasma DHEAS levels for both men and women.

Moderate alcohol consumption is known to have positive, possibly even protective, cardiovascular health effects. A study in the May issue of Alcoholism: Clinical & Experimental Research investigates the role that certain hormones may play in the cardiovascular benefits of alcohol, specifically, dehydroepiandrosterone sulfate (DHEAS), testosterone and estradiol. Researchers found that moderate alcohol consumption can increase plasma DHEAS levels for both men and women, decrease plasma testosterone among men, and has no effect on plasma estradiol levels.

"DHEAS is believed to play a protective role against atherosclerosis in both genders," said Henk F.J. Hendriks, a senior scientist at TNO Nutrition and Food Research in The Netherlands and corresponding author for the study, "just like low testosterone does for men." Atherosclerosis is characterized by irregularly distributed lipid deposits in the arteries, which can provoke fibrosis and calcification, impede blood flow, and/or eventually shut off blood flow. "This is the first diet-controlled intervention study which shows that moderate alcohol drinking can increase DHEAS," he added.

"Estradiol, or estrogens in general," Hendriks continued, "may be pivotal in the protection from coronary heart disease in premenopausal women. An association between moderate alcohol consumption and breast cancer has been proposed, which may be mediated through an increase in estradiol."

"A lot of the earlier work in this area looked at hormones because of associations that had been found between alcohol and breast canc
'"/>


13-May-2004


Page: 1 2 3

Related biology news :

1. Moderate iron deficiency affects cognitive performance - but iron supplementation improves it
2. Moderate alcohol consumption after meals can decrease levels of insulin
3. Moderate alcohol consumption during pregnancy is risky too
4. Moderate vitamin E supplementation may lower diabetics cardiovascular risk
5. Moderate alcohol consumption increases bone mineral density in elderly women
6. Moderate alcohol consumption may reduce your chances of a heart attack
7. Moderate caffeine use does not increase miscarriage risk but high caffeine use doubles risk
8. Duke Researchers Finds That Moderate Caffeine Use Boosts Blood Pressure, Potential For Heart Disease
9. Even Moderate Air Pollution Reaching Eastern Wilderness Decreases Mountain Hikers Lung Function
10. No Such Luck: Nitrogen From Air Pollution Unlikely to Moderate Global Warming
11. A liking for sweets, combined with novelty seeking, may predict alcoholism

Post Your Comments:
(Date:12/5/2014)... , Dec. 4, 2014 Increased emphasis ... investments in new testing and inspection technologies. The ... rise to a range of innovative test solutions. ... of Generation Y, which is generally more inclined ... result, product development strategies of test equipment vendors ...
(Date:12/4/2014)... BEACH GARDENS, Fla. , Dec. 3, 2014 ... management solutions, today announced that its DigitalPersona ® ... 4500 fingerprint readers have been deployed throughout First ... , South Carolina ... headquartered in Southern Pines, North Carolina ...
(Date:12/3/2014)... GLENDALE, Ariz. , Dec. 2, 2014 ... biometric hand readers, Inception Technologies is pleased to announce ... it easier for customers to collect the workforce data ... the problems that have been left by existing readers. ... to user interface, connectivity and modern technology. Older models ...
Breaking Biology News(10 mins):Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3Inception Technologies to Release New Biometric Reader 2
(Date:12/17/2014)...  United Therapeutics Corporation (NASDAQ: UTHR ) ... changes to Martine Rothblatt , Ph.D,s compensation program. ... United Therapeutics announced the promotion of Roger Jeffs ... David Zaccardelli , Pharm.D. to Executive Vice President ... Dr. Rothblatt,s title will change from Chairman and Chief ...
(Date:12/17/2014)... Calif. , Dec. 17, 2014 ... a Phase 2 study evaluating the investigational oral ... of patients with severe, chronic itch who are ... of care, including topical steroids and antihistamines. ... change in Visual Analog Scale (VAS) itch score ...
(Date:12/15/2014)... 15, 2014 METTLER TOLEDO is ... tool, ParticleView V19 with PVM technology , ... particle vision and measurement tool continuously captures high-resolution ... ParticleView V19 then automatically prepares a report pairing ... size and concentration changes. This compelling blend of ...
(Date:12/15/2014)... SAN DIEGO , Dec. 15, 2014 /PRNewswire/ ... a three-dimensional biology company focused on delivering breakthrough ... by the industry and collaborators of its exVive3D ... was made widely available in full commercial release ... in the field, resulting in several awards for ...
Breaking Biology Technology:United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 2United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 3United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 4Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4New Real-Time In Situ Probe-Based Video Microscope from METTLER TOLEDO 2Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 2Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 3
Cached News: